Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Impact of Different Carrier Solutions for House Dust Mite Allergen (HDM) Challenge on Allergic Reactions in Patients with HDM Allergic Rhinitis

NCT05245175 is registered in ClinicalTrials.gov with Fraunhofer-Institute of Toxicology and Experimental Medicine as lead sponsor.

NCT NCT05245175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05245175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Impact of Different Carrier Solutions for House Dust Mite Allergen (HDM) Challenge on Allergic Reactions in Patients with HDM Allergic Rhinitis
Lead sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2022
Completion date
April 13, 2022
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis